Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the ...
Good news for anyone who thought Fitbit's move toward the smartwatch market would be a move away from health: The wearable maker has just announced a partnership with Dexcom that will bring data from ...
スマートリングメーカーの Oura は11月19日、血糖値測定器メーカーの Dexcom から7,500万ドルの投資を受けたと発表した。これにより Oura の企業評価額は50億ドルを超え、両社は2025年上半期からデバイスとアプリの連携サービスを開始する予定だ。 同社の公式 ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...
Employer-focused global fertility company Carrot announced a partnership with health-tracking ring maker Oura and continuous glucose monitoring company Dexcom to combine fertility and family-building ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
This new technology utilizes data from the Dexcom G7 15 Day sensor to provide personalized insulin recommendations. Alongside this development, DexCom released its third-quarter earnings, reporting a ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する